Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Azilsartan

Azilsartan (TAK-536) is an orally active, potent, selective and specific angiotensin II type 1 receptor (AT1) antagonist. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity. Azilsartan can be used for hypertension and stroke research[1][2][3][4][5].

Product Specifications

CAS Number

147403-03-0

Product Name Alternative

TAK-536

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Angiotensin Receptor; Apoptosis; Reactive Oxygen Species (ROS)

Type

Reference compound

Related Pathways

Apoptosis; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Metabolic Disease; Neurological Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Azilsartan.html

Purity

99.68

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C(N5)=NOC5=O)C=C3)=CC=C1)O

Molecular Formula

C25H20N4O5

Molecular Weight

456.45

Precautions

H302, H315, H319, H335

References & Citations

[1]Kajiya T, et al. Molecular and cellular effects of azilsartan: a new generation angiotensin II receptor blocker. J Hypertens. 2011 Dec;29 (12) :2476-83.|[2]Zhao M, et al. Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats. Diabetes Obes Metab. 2011 Dec;13 (12) :1123-9.|[3]Ojima M, et al. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies. J Pharmacol Exp Ther. 2011 Mar;336 (3) :801-8. |[4]Gupta V, et al. Neuroprotective potential of azilsartan against cerebral ischemic injury: Possible involvement of mitochondrial mechanisms. Neurochem Int. 2020 Jan;132:104604.|[5]Ahmadian E, et al. Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2. Biomed Pharmacother. 2018 Mar;99:939-946.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

AT1 Receptor

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

BLM (1319-1335) Rabbit Polyclonal Antibody
AP07900PU-N 50 µg

BLM (1319-1335) Rabbit Polyclonal Antibody

Sign In for Pricing
View Details
Scaf4 Mouse Gene Knockout Kit (CRISPR)
KN515330 1 Kit

Scaf4 Mouse Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Carcinoembryonic Antigen (CEA) / CD66 (C66/1983R), CF568 conjugate, 0.1mg/mL
BNC681983-100 1x 100 µL

Carcinoembryonic Antigen (CEA) / CD66 (C66/1983R), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
6-dR110 [6-Carboxy-4,7-dichlororhodamine 110]
316-AAT 25 mg

6-dR110 [6-Carboxy-4,7-dichlororhodamine 110]

Sign In for Pricing
View Details
PE Anti-Mouse IL-17A Antibody[TC11-18H10.1]
E-AB-F1199UD-01 25 µg

PE Anti-Mouse IL-17A Antibody[TC11-18H10.1]

Sign In for Pricing
View Details
PE Anti-Mouse IL-17A Antibody[TC11-18H10.1]
E-AB-F1199UD-02 100 µg

PE Anti-Mouse IL-17A Antibody[TC11-18H10.1]

Sign In for Pricing
View Details